Navigation Links
Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
Date:9/15/2008

company's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: TREANDA(R) (bendamustine hydrochloride) for Injection, AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA, TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products; interpretation of clinical results, including the results of the FENTORA clinical trials; prospects for final regulatory approval of FENTORA; manufacturing development and capabilities; market prospects for its products, particularly with respect to FENTORA sales and earnings guidance; and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutica
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Theranostics Health Receives Green Light to Perform Clinical Testing
5. StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection
6. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
7. Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351
8. Unique Hearing Aid Receives Patent Protection
9. Tobira Therapeutics Inc. Receives US Patent for TBR-652
10. Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit
11. Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a ... its CGuard TM Embolic Prevention System reported positive results ... , at the EuroPCR conference on May 22, ... PARADIGM, an investigator-initiated P rospective evaluation of A ... I n symptomatic and increased-risk asymptomatic carotid artery stenosis, ...
(Date:5/22/2015)... CITY, Calif. , May 22, 2015 ... pharmaceutical company focused on the development and commercialization of ... pain, today announced that interim chief executive officer ... Healthcare Conference and chief financial officer Tim Morris ... Conference. Details of the two presentations are as follows: ...
(Date:5/21/2015)... , May 21, 2015 ... announced the addition of the "Market Assessment ... Europe" report to their offering. ,     (Logo: ... of the respiratory imaging diagnostics market in ... Europe . The service provides detailed ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... , --Will Shorter Treatments Reduce Drug Resistance?-- ... the largest study of its kind, pediatric researchers at The Children,s Hospital ... the most beneficial method of using antibiotics to treat urinary tract infections ... 2 by the National Institute of Allergy and Infectious Diseases (NIAID), aims ...
... , MENLO PARK, Calif., Sept. 9 ... for the percutaneous repair of cardiac valves, today announced treatment ... at the Elisabethinen Krankenhaus, Linz, Austria. The MitraClip((R)) system is ... which provides a non-surgical mitral valve repair option for patients ...
Cached Medicine Technology:Children's Hospital Receives Six-Year Federal Contract to Study Antibiotic Use in Children With Urinary Tract Infections 2MitraClip(R) Therapy Introduced in Austria 2MitraClip(R) Therapy Introduced in Austria 3
(Date:5/24/2015)... (PRWEB) May 24, 2015 Scientists with ... paper on air quality compliance issues that may have ... workers. Surviving Mesothelioma has just posted an article on ... , The group found airborne asbestos levels well ... collected between 1984 and 2011. , “Asbestos compliance sampling ...
(Date:5/24/2015)... May 24, 2015 Medicx Media ... Media strategy executive Jay Krihak as its head ... to ramp up its expertise and leadership position ... Pharmaceutical and Health sectors. , Krihak is an ... Most recently, Krihak led sales planning teams for ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Dr. David Benvenuti, ... has just posted a new article to his ... As Dr Benvenuti explained in the fascinating blog, ... plugs in their earlobes. , Known as “gauging,” the technique ... hole, which Dr. Benvenuti said will eventually stretch the holes ...
(Date:5/23/2015)... A live auction will be held to sell over 5,200 ... medical facilities around the United States. Various types of ... exam and much more. , The live auction will ... at 9:00am CDT each day. The equipment is at their ... IL 60160. Anyone can participate in the auction including ...
(Date:5/22/2015)... 22, 2015 Pioneer Millworks, the largest ... forefront of designing with reclaimed wood, introducing their latest ... Angeles, California. Their newest offerings, Vat 35, Reclaimed ... and color to America's largest design event. , “Designers, ... each show, anxious to see and feel the variety ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3
... scare of avian flu doesn’t seem to shoo away. In ... samples to neighbouring South Africa. The suspect is of course ... on a hill in the central Ntchisi district.// ... after local villagers started scooping up the dead fork-tailed drongos ...
... dense milk is so there is study in ... products with nutraceutical, pharmaceutical and agrochemical potential.// ... of Queensland's Institute for Molecular Bioscience (IMB) and ... (MST) has teamed up with MG Nutritionals for ...
... family in Karawal Nagar area of northeast Delhi resulting in the ... on Saturday // . ,Apparently the family was sitting beside ... few days ago. In a press meeting deputy commissioner of police ... school building was under construction and the cause of the collapse ...
... against cancer focusing at the molecular and genetic levels, ... coming under increasing scrutiny.// Now scientists at the University ... these supporting cells are indeed key players in the ... ,These findings were arrived at after studying a ...
... Mayo Clinic say that the flagship breast cancer drug, tamoxifen ... common genetic variation. // ,This particular variant gene has ... that is vital to activate tamoxifen against breast cancer. The ... University of Michigan Comprehensive Cancer Center and Matthew Goetz, M.D., ...
... encouraging stereotype body images among their children, according to researchers ... are not spared by their parents, wherein boys are encouraged ... taught how to stay slim. Most mothers were of the ... not, according to the International Journal of Eating Disorders. ...
Cached Medicine News:Health News:Cancer Cells Trigger Supporting Cells to Turn Cancerous 2
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
... Built on the market leading optical performance ... has been optimized for even better views ... system, including a new XHL Xenon Halogen ... cornea and clear, high resolution images of ...
... The New 2.2 Fr Sur-Catch NT stone retrieval ... new level. Its unique paired wire design ... adjusts to the needs of each patient and ... designed specifically for use with the DURTM-8 Elite ...
Medicine Products: